The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved
Open accessAbstract
The insulin receptor (IR) and the insulin-like growth factor I receptor (IGF-IR) have a highly homologous structure, but different biological effects. Insulin and IGF-I half-receptors can heterodimerize, leading to the formation of insulin/IGF-I hybrid receptors (Hybrid-Rs) that bind IGF-I with high affinity. As the IR exists in two isoforms (IR-A and IR-B), we evaluated whether the assembly of the IGF-IR with either IR-A or IR-B moieties may differently affect Hybrid-R signaling and biological role. Three different models were studied: (a) 3T3-like mouse fibroblasts with a disrupted IGF-IR gene (R(-) cells) cotransfected with the human IGF-IR and with either the IR-A or IR-B cDNA; (b) a panel of human cell lines variably expressing the two IR isoforms; and (c) HepG2 human hepatoblastoma cells predominantly expressing either IR-A or IR-B, depending on their differentiation state. We found that Hybrid-Rs containing IR-A (Hybrid-Rs(A)) bound to and were activated by IGF-I, IGF-II, and insulin. By binding to Hybrid-Rs(A), insulin activated the IGF-I half-receptor beta-subunit and the IGF-IR-specific substrate CrkII. In contrast, Hybrid-Rs(B) bound to and were activated with high affinity by IGF-I, with low affinity by IGF-II, and insignificantly by insulin. As a consequence, cell proliferation and migration in response to both insulin and IGFs were more effectively stimulated in Hybrid-R(A)-containing cells than in Hybrid-R(B)-containing cells. The relative abundance of IR isoforms therefore affects IGF system activation through Hybrid-Rs, with important consequences for tissue-specific responses to both insulin and IGFs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,844
DeChiara, T. M., Efstratiadis, A., & Robertsen, E. J. (1990) · Nature · doi:10.1038/345078a0 · Cited by 1,642
Regulation of Cell Motility by Mitogen-activated Protein Kinase
Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., Lanerolle, P. D., & Cheresh, D. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.2.481 · Cited by 1,235
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Self-citationInsulin Action and the Insulin Signaling Network*
CHEATHAM, B., & KAHN, C. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-117 · Cited by 881
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Insulin Action · doi:10.1007/978-1-4615-5647-3_1 · Cited by 667
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
The insulin-like growth factor I receptor: a key to tumor growth?
Baserga, R. (1995) · PubMed · Cited by 552
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006806722619 · Cited by 534
Monoclonal antibodies to receptors for insulin and somatomedin-C.
Kull, F. C., Jacobs, S., Su, Y. F., Svoboda, M. E., Van Wyk, J. J., & Cuatrecasas, P. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32449-9 · Cited by 423
Growth-Promoting Interaction of IGF-II with the Insulin Receptor during Mouse Embryonic Development
Louvi, A., Accili, D., & Efstratiadis, A. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8666 · Cited by 397
Functionally distinct insulin receptors generated by tissue-specific alternative splicing.
Mosthaf, L., Grako, K., Dull, T. J., Coussens, L., Ullrich, A., & McClain, D. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07416.x · Cited by 366
Insulin signal transduction through protein kinase cascades
Avruch, J. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006823109415 · Cited by 365
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338
Self-citationTissue-Specific Expression of Two Alternatively Spliced Insulin Receptor mRNAs in Man
Moller, D. E., Yokota, A., Caro, J. F., & Flier, J. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1263 · Cited by 324
Expression and characterization of a functional human insulin-like growth factor I receptor.
Steele-Perkins, G., Turner, J., Edman, J. C., Hari, J., Pierce, S. B., Stover, C., Rutter, W. J., & Roth, R. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37983-3 · Cited by 314
Sciacca, L., Costantino, A., Pandini, G., Mineo, R., Frasca, F., Scalia, P., Sbraccia, P., Goldfine, I. D., Vigneri, R., & Belfiore, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202600 · Cited by 288
Self-citationBAILYES, E. M., NAVÉ, B. T., SOOS, M. A., ORR, S. R., HAYWARD, A. C., & SIDDLE, K. (1997) · Biochemical Journal · doi:10.1042/bj3270209 · Cited by 278
Papa, V., Gliozzo, B., Gm, C., McGuire, W. L., Moore, D. H., Fujita‐Yamaguchi, Y., Vigneri, R., Goldfine, I. D., & PEZZINO, V. (1993) · PubMed · Cited by 276
Self-citationSoos, M. A., Field, C. E., & Siddle, K. (1993) · Biochemical Journal · doi:10.1042/bj2900419 · Cited by 275
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Self-citationThe Insulin Receptor and Its Cellular Targets1
Kido, Y., Nakae, J., & Accili, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7306 · Cited by 223
Dupont, J., & LeRoith, D. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063469 · Cited by 216
Soos, M. A., Whittaker, J., Lammers, R., Ullrich, A., & Siddle, K. (1990) · Biochemical Journal · doi:10.1042/bj2700383 · Cited by 201
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor
Soos, M. A., Siddle, K., Baron, M. D., Heward, J. M., Luzio, J. P., Bellatin, J., & Lennox, E. S. (1986) · Biochemical Journal · doi:10.1042/bj2350199 · Cited by 200
The IGF system in thyroid cancer: new concepts
Vella, V, Sciacca, L., Pandini, G., Mineo, R., Squatrito, S., Vigneri, R., & Belfiore, A. (2001) · Molecular Pathology · doi:10.1136/mp.54.3.121 · Cited by 177
Self-citationPhysiological signals and oncogenesis mediated through Crk family adapter proteins
Feller, S. M., Posern, G., Voss, J., Kardinal, C., Sakkab, D., Zheng, J., & Knudsen, B. S. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199812)177:4<535::aid-jcp5>3.0.co;2-e · Cited by 143
Insulin and IGF-I Receptors Signaling in Protection from Apoptosis
di Prisco, M., Romano, G., Peruzzi, F., Valentinis, B., & Baserga, R. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978703 · Cited by 131
Frattali, A. L., & Pessin, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53187-2 · Cited by 127
Roth, R. A., Cassell, D. J., Wong, K. Y., Maddux, B. A., & Goldfine, I. D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7312 · Cited by 120
Sasaoka, T., Ishiki, M., Sawa, T., Ishihara, H., Takata, Y., Imamura, T., Usui, I., Olefsky, J. M., & Kobayashi, M. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828504 · Cited by 119
Soos, M. A., Field, C. E., Lammers, R., Ullrich, A., Zhang, B., Roth, R. A., Andersen, A. S., Kjeldsen, T., & Siddle, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42367-8 · Cited by 116
Forsayeth, J., MONTEMURRO, A., Maddux, B. A., DePirro, R., & Goldfine, I. D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61322-5 · Cited by 109
Kosaki, A., & Webster, N. J. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80638-3 · Cited by 107
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer
Belfiore, A., Pandini, G., Vella, V., Squatrito, S., & Vigneri, R. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80088-1 · Cited by 106
Self-citationLaviola, L., Giorgino, F., Chow, J. C., Baquero, J. A. G., Hansen, H. F., Ooi, J., Zhu, J., Riedel, H., & Smith, R. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119246 · Cited by 103
Flier, J. S., Moller, D. E., Moses, A. C., O’Rahilly, S., Chaiken, R. L., Grigorescu, F., Elahi, D., Kahn, B. B., Weinreb, J. E., & Eastman, R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8388881 · Cited by 87
Kasuya, J., Paz, I. B., Maddux, B. A., Goldfine, I. D., Hefta, S. A., & Fujita-Yamaguchi, Y. (1993) · Biochemistry · doi:10.1021/bi00212a019 · Cited by 79
Federici, M., Zucaro, L., Porzio, O., Massoud, R. G., Borboni, P., Lauro, D., & Sesti, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119117 · Cited by 79
A functional assessment of insulin/insulin-like growth factor-I hybrid receptors
Seely, B. L., Reichart, D. R., Takata, Y., Yip, C., & Olefsky, J. M. (1995) · Endocrinology · doi:10.1210/en.136.4.1635 · Cited by 79
Mechanism of Insulin and IGF‐I
MEYTS, P. D., Ursø, B., Christoffersen, C. T., & Shymko, R. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26688.x · Cited by 66
Federici, M., Porzio, O., Lauro, D., Borboni, P., Giovannone, B., Zucaro, L., Hribal, M. L., & Sesti, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4935 · Cited by 66
Belfiore, A., Costantino, A., Frasca, F., Pandini, G., Mineo, R., Vigneri, P. G., Maddux, B. A., Goldfine, I. D., & Vigneri, R. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1318 · Cited by 56
Self-citationGANDERTON, R. H., Stanley, K. K., Field, C. E., Coghlan, M., Soos, M. A., & Siddle, K. (1992) · Biochemical Journal · doi:10.1042/bj2880195 · Cited by 47
Sbraccia, P., D’Adamo, M., Leonetti, F., Caiola, S., Iozzo, P., Giaccari, A., Buongiorno, A. M., & Tamburrano, G. (1996) · Diabetologia · doi:10.1007/bf00403966 · Cited by 36
Spampinato, D., Pandini, G., Iuppa, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6977 · Cited by 12
Self-citation
Cited by
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Mechanisms of receptor tyrosine kinase activation in cancer
Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Self-citation
Metadata
- Authors
- Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 277
- Issue
- 42
- Pages
- 39684-39695
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1967899512
- Cited by
- 500
- References
- 46
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.